UNSPSC 51152010: Rapacuronium

This classification denotes a muscle relaxant with the molecular formula C37H61N2O4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65Q4QDG4KC, chemically known as piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidinyl)androstan-16-yl)-1-(2-propenyl)-, bromide but generally known as rapacuronium bromide, which bears US NIH Compound Identifier 177969.

UNSPSC 51152010 Rapacuronium is a Commodity code that covers pharmaceutical supplies, though recent state and local solicitations under this code show minimal alignment with the narrow rapacuronium-specific scope. The Seminole County, Florida procurement IFB60459723LAS — an IFB posted June 30, 2026, due July 26, 2026 — solicits 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding for community health initiatives. The Texas Health and Human Services Commission's concurrent RFI HHS0017013, posted April 3, 2026, explores vendor capabilities for direct-to-manufacturer prescription programs serving self-insured employee health plans and state agencies. These opportunities indicate that state and local procurement under this code encompasses broader pharmaceutical and drug-response products rather than rapacuronium specifically. Issuing bodies include county health departments and state health-and-human-services agencies pursuing community health and pharmacy benefit programs.

Recent activity concentrates in Florida and Texas. Seminole County's Naloxone and drug-deactivation procurement requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs and subject to E-Verify compliance, drug-free workplace certification, workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary termination clause. The Texas HHS RFI, by contrast, operates as exploratory market research rather than a binding solicitation, seeking vendor information on direct contracting capacity, negotiated net-pricing models, and outcomes-based agreements before the state issues a formal RFP. No set-asides or disadvantaged-enterprise designations appear in either opportunity. The code shows limited recent activity overall, and the opportunities posted do not center on rapacuronium procurement per the code's nominal scope.